Experience

Davis Polk advised Kingsoft Cloud Holdings Limited and certain selling shareholders on its approximately $509 million SEC-registered follow-on public offering of 16,421,576 American…

 Davis Polk advised ADC Therapeutics SA on its SEC-registered offering of 6,000,000 common shares for total gross proceeds of $204 million. ADC Therapeutics is listed on the New York…

Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of $500 million aggregate principal amount of its floating-rate senior notes due 2023, under its medium-term…

Davis Polk advised Zai Lab Limited in connection with its secondary listing and initial public offering on the Hong Kong Stock Exchange. Zai Lab is the first company listed under both…

Davis Polk advised the lead manager, sole book-runner and representative of the several underwriters in connection with an SEC-registered offering by Bank of America Corporation…

Davis Polk advised NatWest Group plc in connection with its cash tender offer for any and all of certain series of its outstanding bank capital securities.NatWest Group is the holding…

Davis Polk advised the joint bookrunners and representatives of the several underwriters in connection with concurrent SEC-registered offerings by (1) B.A.T Capital Corporation of $1.75…

Davis Polk advised the representatives of the several underwriters in connection with the $1.3 billion initial public offering of 39,807,691 shares of Class A common stock of GoodRx…

Davis Polk advised Ming Yuan Cloud Group Holdings Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in…

Davis Polk advised the representatives of the initial purchasers in a Rule 144A offering by Omnicell, Inc. of $575 million aggregate principal amount of 0.25% convertible senior notes due…